FDA Approves MenQuadfi Meningococcal Vaccine for Six-Week-Old Infants
The U.S. Food and Drug Administration (FDA) has licensed Sanofi’ SA’s four-valent MenQuadfi meningococcal vaccine for use in infants aged six weeks to 23 months old to prevent invasive meningococcal disease. Previously approved for children aged two and older, MenQuadfi is now the first meningococcal vaccine included on the U.S. Centers for Disease Control and […]
Shingles May Be Triggered by Covid Shots
A large retrospective cohort study conducted by researchers in Germany and the University of Virginia compared the incidence of shingles among individuals who did and did not get a Covid-19 shot and found a statistically significant difference providing evidence for an association between Covid vaccinations and increased risk for developing shingles or herpes zoster (HZ). […]